News

Scientists know some viral infections can cause cancer later in life. Now, researchers at the UCSF Brain Tumor Center have identified a link between the genetic risk factors for glioma and the immune response to certain common viruses.

For Reno teenager Olivia Tillis, painting shoes is more than just a hobby – it is a way to honor her mother’s memory, while also giving back to the brain tumor community. Olivia’s mother, Rosie Tillis, was diagnosed with glioblastoma in 2017 and passed away almost two years later.

While various immunotherapies work through different mechanisms, they are all designed to enhance the immune system’s ability to recognize and target cancer cells. Pembrolizumab does so by binding and inhibiting PD-1, a protein that normally protects the body from attacking itself.

The newly released 2021 WHO Classification of Tumors of the Central Nervous System (CNS) introduces major changes that advance the role of molecular profiling in CNS tumor classification and includes ma

Previous immunotherapies like CAR T cells were designed to target glioblastoma cells, but were only effective in killing a portion of the cells – leaving some cancer cells behind, and allowing for tumor recurrence.